8-KThe WireStrategic
Results of Operations · Reg FD Disclosure
Filed Mar 19, 2026 · 3mo ago · Accession 0001193125-26-115139
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Acrivon Therapeutics, Inc.
- Ticker
- ACRV
- CIK
- 1781174
- Form type
- 8-K
- Filing date
- Mar 19, 2026
- Report date
- Mar 19, 2026
- Document
- acrv-20260319.htm
- Size
- 24.8 MB